Prelude Therapeutics Incorporated (PRLD) - Quarterly Income Statement

Home
PRLD
Financials

2.55 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	3.424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.452	0.426	0.331	0.279	0.723	0.71	0.799	0.776	0.749	0.718	0.69	0.622	0.489	0.442	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-0.452	-0.426	3.093	-0.279	-0.723	-0.71	-0.799	-0.776	-0.749	-0.718	-0.69	-0.622	-0.489	-0.442	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	29.509	27.409	30.332	26.261	24.966	21.834	25.869	22.889	21.31	22.821	25.178	22.721	22.409	16.47	14.572	15.293	9.776	8.536	8.849	5.49	4.97	4.97
General & Administrative Expenses Numbers are in millions	7.655	6.934	7.047	7.124	7.432	7.281	7.516	7.517	8.151	7.467	7.832	8.115	5.513	5.497	4.874	2.851	1.66	1.201	1.246	1.394	0.595	0.595
Selling & Marketing Expenses Numbers are in millions	-0.452	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	7.203	6.934	7.047	7.124	7.432	7.281	7.516	7.517	8.151	7.467	7.832	8.115	5.513	5.497	4.874	2.851	1.66	1.201	1.246	1.394	0.595	0.595
Other Expenses Numbers are in millions	2.424	2.912	4.304	2.777	1.967	1.397	4.744	0.448	2.087	0.823	0.168	0.149	1.057	0.667	0.196	1.384	0.028	0.226	0.056	0.15	0	0
Operating Expenses Numbers are in millions	36.712	34.343	37.379	33.385	32.398	29.115	33.385	30.406	29.461	30.288	33.01	30.836	27.922	21.967	19.446	18.144	11.436	9.737	10.095	6.884	5.399	5.399
Operating Income Numbers are in millions	-37.164	-34.343	-37.379	-33.385	-32.398	-29.115	-33.385	-30.406	-29.461	-30.288	-33.01	-30.836	-27.922	-21.967	-19.446	-18.144	-11.436	-9.737	-10.095	-6.884	-5.565	-5.565
Operating Income Ratio Numbers are in millions	0	0	-10.917	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	2.424	2.912	4.304	2.777	1.967	1.397	4.744	0.448	2.087	0.823	0.168	0.149	1.057	0.667	0.196	1.384	0.028	0.226	0.056	0.15	0.167	0.167
Income Before Tax Numbers are in millions	-34.74	-31.431	-33.075	-30.608	-30.431	-27.718	-28.641	-29.958	-27.374	-29.465	-32.842	-30.687	-26.865	-21.3	-19.25	-16.76	-11.408	-9.511	-10.039	-6.734	-5.399	-5.399
Income Before Tax Ratio Numbers are in millions	0	0	-9.66	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-0.426	1.676	-0.279	0.239	-1.397	-7.654	-0.448	-2.087	-0.823	-0.168	-0.356	-0.29	-0.282	0	0	0	0	0	0	0	0
Net Income Numbers are in millions	-34.74	-31.431	-33.075	-30.608	-30.431	-26.321	-20.987	-29.51	-25.287	-28.642	-32.842	-30.687	-26.865	-21.3	-19.25	-16.76	-11.408	-9.511	-10.039	-6.734	-5.399	-5.399
Net Income Ratio Numbers are in millions	0	0	-9.66	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.46	-0.42	-0.48	-0.45	-0.54	-0.55	-0.44	-0.62	-0.53	-0.61	-0.71	-0.66	-0.58	-0.47	-0.51	-0.44	-0.3	-0.29	-0.31	-0.21	-3.43	-3.43
EPS Diluted Numbers are in millions	-0.46	-0.42	-0.48	-0.45	-0.54	-0.55	-0.44	-0.62	-0.53	-0.61	-0.71	-0.66	-0.58	-0.47	-0.51	-0.44	-0.3	-0.29	-0.31	-0.21	-3.42	-3.42
EBITDA Numbers are in millions	-36.712	-34.343	-37.048	-33.385	-32.117	-28.837	-33.023	-30.069	-29.143	-29.981	-32.72	-30.57	-27.723	-21.807	-19.313	-18.002	-11.301	-9.605	-9.967	-6.785	-5.488	-5.488
EBITDA Ratio Numbers are in millions	0	0	-10.82	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Prelude Therapeutics Incorporated

NASDAQ:PRLD Add to watchlist

NASDAQ:PRLD